Skip to main content
65°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
100.16
+0.56 (+0.56%)
Streaming Delayed Price
Updated: 2:58 PM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novartis Ag ADR
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
38
39
Next >
Regenerative Medicine Market Growing at a CAGR of 15.9% – Rising Demand for Organ Transplantations
September 14, 2021
The global regenerative medicine market is expected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.
Via
SBWire
Exposures
Product Safety
Why Regenxbio Stock Is Way Up Today
September 13, 2021
American biopharmaceutical giant AbbVie wants access to Regenexbio's gene therapy for macular degeneration.
Via
The Motley Fool
ADHD Drug Developer Cingulate Plans NASDAQ Debut
September 10, 2021
Cingulate Inc filed for an IPO, penciling in a modest $58 million raise, and expects to list on NASDAQ under CING ticker. Cingulate has a Phase 3-ready attention...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
What may be behind achy, tired, or burning eyes? Dry eye disease may be the culprit.
September 09, 2021
(BPT) - Sponsored by Novartis Pharmaceuticals Corporation.
Via
Brandpoint
Exposures
COVID-19
Why Did Wedbush Downgrade Xoma?
September 07, 2021
Wedbush has cut XOMA Corporation (NASDAQ: XOMA) to neutral from outperform and lowered its price target to $22 from $41. Analyst Liana Moussatos notes ...
Via
Benzinga
DGTL is First Enabled to Convert and Distribute Social Media Influencer Content to Programmatic Web Ads
September 07, 2021
New York, New York--(Newsfile Corp. - September 7, 2021) - DGTL Holdings Inc. (TSXV: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L) ("DGTL"...
Via
Newsfile
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Novartis Stops Iscalimab Trial In Kidney Transplant Patients
September 03, 2021
Novartis AG (NYSE: NVS) has halted a Phase 2 trial of CFZ533 (iscalimab) in kidney transplant patients. The decision follows interim data that showed iscalimab was...
Via
Benzinga
Price Over Earnings Overview: Novartis
September 02, 2021
Looking into the current session, Novartis Inc. (NYSE:NVS) is trading at $92.23, after a 0.45% drop. Over the past month, the stock decreased by 0.02%, but over the...
Via
Benzinga
The Rising Delta Variant
September 01, 2021
China is not only cracking down on kiddie playtime. It also is absorbing bankruptcy claims from real estate developer Evergrande.
Via
Talk Markets
Topics
Bankruptcy
Exposures
Financial
Legal
Coherra Continue to Add Strength to the Organization and Cap Table With the Appointment of Thomas Ebeling as a New Member of the Advisory Board
September 01, 2021
Coherra is strengthening its global business development ahead of the scaling phase with the appointment of Thomas Ebeling as Advisory Board Member. Thomas will be working with Coherra's founder, Søren...
Via
Newswire.com
Novartis, NHS England Ink Access Deal For Cholesterol Drug Leqvio
September 01, 2021
The U.K. government, NHS England, and Novartis AG (NYSE: NVS) unveiled a "world-first" reimbursement deal for providing broader access to anti-cholesterol...
Via
Benzinga
DGTL Holdings Inc. Reports the Completion of Software Development for Hashoff 2.0
August 31, 2021
New York, New York--(Newsfile Corp. - August 31, 2021) - DGTL Holdings Inc. (TSXV: DGTL) (OTCQB: DGTHF) (FSE: D0G) (WKN:...
Via
Newsfile
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Vision Care Products Market Giants Spending Is Going to Boom with CooperVision, Essilor International S.A., Carl Zeiss Meditec
August 30, 2021
Vision Care Products Comprehensive Study by Type (Eye Glasses (Single Vision Eyeglasses, Bifocal Eyeglasses, Progressive Eyeglasses), Contact Lens (Personalized/Custom, Specific Care, Single Vision,...
Via
SBWire
UCB Gets EU Approval For Bimekizumab In Psoriasis
August 25, 2021
The European Commission has cleared UCB's (OTC: UCBJF) Bimzelx (bimekizumab) for moderate to severe plaque psoriasis in adults. UCB's confidence lies in...
Via
Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Living with Chronic Hives: One Woman’s Story
August 25, 2021
(BPT) - Ilana, a board-certified emergency medicine physician, lived with chronic hives for almost as long as she can remember. 'I've had them since I was at least 8 years old,' she says. 'It's...
Via
Brandpoint
Exposures
Product Safety
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
August 25, 2021
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Exposures
COVID-19
Novartis' STAMP Inhibitor Under FDA Review For Myeloid Leukemia
August 25, 2021
The FDA has accepted for review Novartis AG's (NYSE: NVS) marketing application seeking approval for asciminib (ABL001) in chronic myeloid leukemia (CML)....
Via
Benzinga
Exposures
Product Safety
Reuters Events Announces the Shortlist for the 12th Annual Responsible Business
August 25, 2021
SOURCE: Reuters Events Sustainable Business
Via
3BL Media
Topics
Emissions
Stocks
Exposures
COVID-19
US Equities
Only The Conservative Pot Stocks Index Is Up YTD And Currently Yields 4.9%
August 25, 2021
If you were to invest in a basket of the major companies that have bought into marijuana companies you could possibly generate greater returns than only owning the associated marijuana company.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Novartis's Kymriah Flunks In Late-Stage NHL Study
August 24, 2021
Novartis AG's (NYSE: NVS) Kymriah (tisagenlecleucel) CAR-T therapy failed to meet its primary endpoint of event-free survival in a Phase 3 study in aggressive...
Via
Benzinga
Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?
August 23, 2021
If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the...
Via
Talk Markets
Exposures
Product Safety
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
August 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...
Via
Benzinga
Exposures
Product Safety
DGTL Holdings Inc. Opens APAC Market with Major Asian Airline as New Key Account Customer
August 23, 2021
New York, New York--(Newsfile Corp. - August 23, 2021) - DGTL Holdings Inc. (TSXV: DGTL) (OTCQB: DGTHF) (WKN: A2QB0L)...
Via
Newsfile
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
PYXERA Global Webinar Seeks to Disrupt International Development's Legacy of Injustice
August 23, 2021
SOURCE: PYXERA Global
Via
3BL Media
Children Cough Medicine Market to See Huge Growth by 2021-2026 : Bayer, Sanofi, Hyland's
August 23, 2021
The latest analysis released by HTF MI on "Worldwide Children Cough Medicine Market Outlook 2020 Survey results" sheds light on how investment and competitive landscape is impacted due to significant...
Via
SBWire
Topics
Supply Chain
Exposures
Supply Chain
Active Pharmaceutical Ingredients Market worth $248.3 billion by 2025 | Key Players are Pfizer Inc. (US), Novartis International AG (Switzerland), Merck & Co. (US)
August 19, 2021
Via
AB Newswire
BEE Hits 10K Subscribers for BEE Pro, Company Poised to Accelerate Growth in H2
August 18, 2021
Companies such as Netflix, Harpercollins, Boston College, Novartis, Unicef, and Save the Children rely on BEE Pro to speed up & streamline email and landing page design.
Via
News Direct
Transplantation Market Detailed Research Report, 2025 – Top Companies Involve Veloxis Pharmaceuticals, BioLifeSolutions, Stryker, Medtronic, Arthrex And Novartis | Million Insights
August 18, 2021
Via
AB Newswire
Advancement in Connectivity Technology Expected to Enhance the Growth of the Biosimilars Market During the Projected Period 2021-2027
August 17, 2021
Advancement in Connectivity Technology Expected to Enhance the Growth of the Biosimilars Market during the Projected Period 2021-2027
Via
SBWire
Topics
Economy
Exposures
COVID-19
Economy
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.